Lv1
38 积分 2024-03-31 加入
Combination cis-platinum and etoposide in small-cell lung cancer
1小时前
求助中
Camrelizumab plus carboplatin and pemetrexed as first-line therapy for advanced non-squamous non-small-cell lung cancer: 5-year outcomes of the CameL randomized phase 3 study
2天前
已完结
Dose-dependent efficacy of bevacizumab in recurrent glioblastoma
14天前
已完结
Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Treatment and RAS Mutations in Colorectal Cancer
1个月前
已完结
Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial
1个月前
已完结
Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC
1个月前
已完结
A phase 3 randomized, double-blind, placebo-controlled study of durvalumab in combination with gemcitabine plus cisplatin (GemCis) in patients (pts) with advanced biliary tract cancer (BTC): TOPAZ-1
1个月前
已完结
Neoadjuvant Treatment of Mismatch Repair–Deficient Colon Cancer — Clinically Meaningful?
3个月前
已完结
[Clinical and chest CT features of immune checkpoint inhibitor-related pneumonitis]
4个月前
已完结
CLAUDIN-18.2 TESTING AND ITS IMPACT IN THE THERAPEUTIC MANAGEMENT OF PATIENTS WITH GASTRIC AND GASTROESOPHAGEAL ADENOCARCINOMAS: A LITERATURE REVIEW WITH EXPERT OPINION
4个月前
已完结
皖公网安备34019202002308
